Renal Sympathetic Denervation for Patients With Chronic Heart Failure (RSD4CHF)
Safety and Effectiveness Study of Percutaneous Catheter-base Renal Sympathetic Denervation for Patients With Chronic Heart Failure
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Listed as NCT01790906, this NA trial focuses on Chronic Heart Failure and remains ongoing. Sponsored by The First Affiliated Hospital with Nanjing Medical University, it has been updated 6 times since 2013, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
May 2017 — Jun 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — May 2017 [monthly]
Recruiting NA
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The First Affiliated Hospital with Nanjing Medical University
For direct contact, visit the study record on ClinicalTrials.gov .